According to the recent report by IMARC Group, entitled “Biosimilar Market Size: Global Industry Trends, Share, Growth, Opportunity and Forecast 2022-2027”, The market reached a value of US$ 13.0 Billion in 2021.Biosimilars, also known as subsequent entry biologics (SEBs) or follow-on biologics, refer to FDA-approved biotherapeutic products which are similar to their reference biologics. Biosimilars can only be manufactured after the patent of the reference product expires. The demand for biosimilars has been increasing in recent years as they help in reducing the overall cost of the treatment for a variety of chronic diseases including cancers, autoimmune diseases, kidney failure, diabetes, CVDs, haematological disorders, infectious diseases, rheumatoid arthritis, growth hormone deficiency, etc.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request for a PDF sample of this report: https://www.imarcgroup.com/biosimilar-market/requestsample
Recent patent expiries of a large number of blockbuster biological drugs such as Humira, Remicade, MabThera, Enbrel, etc. have majorly boosted the growth of the biosimilar market. Another major growth-inducing factor is ageing population which has led to a rise in the prevalence of non-communicable diseases. Further, high costs of innovator biologics, especially monoclonal antibodies (mAbs), have encouraged several governments across the globe to promote the usage of biosimilars. For instance, European countries like the Netherlands, Denmark and Germany have established strategic models for discount pricing and introduced numerous incentive programs. Apart from this, biosimilars do not require extensive marketing as the safety and efficacy profile of biologics has already been established. This has resulted into the low cost of these drugs in comparison to their branded counterparts, in turn, spurring their demand worldwide. Catalyzed by these factors, the market is expected to reach US$ 60.8 Billion by 2027, exhibiting at a CAGR of 26.1% during 2022-2027.
Checkout Now: https://www.imarcgroup.com/checkout?id=2073&method=1
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
- Merck & Co
- Samsung Bioepis
- Eli Lilly
- Reddy’s Laboratories
- Boehringer Ingelheim
- Insulin Glargine
- Epoetin Alfa
- Follitropin Alfa
- Auto-Immune Diseases
- Blood Disorder
- Growth Deficiency
- Female Infertility
- In-house Manufacturing
- Contract Manufacturing
- United States
- United Kingdom
- South Korea
Explore full report with TOC & List of Figures: https://www.imarcgroup.com/biosimilar-market
We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Microencapsulation Market: https://www.imarcgroup.com/microencapsulation-market
Automotive Connectors Market Report: https://www.imarcgroup.com/automotive-connectors-market
North America Microgrid Market: https://www.imarcgroup.com/north-america-microgrid-market
Oxo Alcohol Market: https://www.imarcgroup.com/oxo-alcohol-technical-material-market-report
Mechanical Ventilators Market Price Trends: https://www.imarcgroup.com/mechanical-ventilators-market
Smart Mirror Market Price Trends: https://www.imarcgroup.com/smart-mirror-market
GCC Oral Hygiene Market: https://www.imarcgroup.com/gcc-oral-hygiene-market
Acute Myeloid Leukemia Therapeutics Market: https://www.imarcgroup.com/acute-myeloid-leukemia-therapeutics-market
Natural Killer Cells Therapeutics Market: https://www.imarcgroup.com/natural-killer-cells-therapeutics-market
Automotive connectors market Report: https://www.imarcgroup.com/automotive-connectors-market
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Group 30 N Gould St Ste R Sheridan, WY 82801 USA - Wyoming Email: [email protected] Tel No:(D) +91 120 433 0800 Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
PR-Wirein, Reportedtimes, iCN Internal Distribution, Research Newswire, English